21 January 2019 - Deborah Wilkes
Archived
The US Food and Drug Administration (FDA) is making "unprecedented new efforts" to support the switch of naloxone from prescription to OTC status.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.